Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models
- PMID: 39453502
- DOI: 10.1007/s00210-024-03529-2
Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models
Abstract
Chronic stress is significantly implicated in the worsening of autoimmune disorders, contributing to elevated inflammation and diminished therapeutic efficacy. Here, in this study, we investigated the detrimental impact of an 8-week chronic unpredictable stress (CUS) protocol on the progression of arthritis and psoriasis using collagen-induced arthritis (CIA) and imiquimod (IMQ)-induced psoriasis rat models, respectively. Our objective was to elucidate how prolonged stress exacerbates disease severity and impairs the effectiveness of treatment drug. Following the induction of CIA and IMQ, rats were subjected to an 8-week CUS paradigm designed to simulate chronic stress conditions. Moreover, after 5 weeks of CUS, methotrexate (MTX; 2 mg/kg, administered once weekly for 3 weeks, intraperitoneally) was introduced as a therapeutic intervention. The severity of CUS-induced effects and the therapeutic impairment of MTX in arthritis and psoriasis rats were assessed through pathological examination of joint and epidermal tissues, respectively. Additionally, we measured various pro-inflammatory cytokine levels, including NF-κB (nuclear factor kappa B), IFN-γ (interferon-gamma), TNF-α (tumour necrosis factor alpha), IL (interleukin)-1β, IL-6, IL-17 and IL-23 using enzyme-linked immunosorbent assay (ELISA), analysed immune cells through complete haematological profiling and evaluated oxidative stress markers. Our findings revealed that CUS significantly aggravated the pathological features of both arthritis and psoriasis. Prolonged stress exposure led to heightened inflammatory responses, increased oxidative stress and more severe tissue damage. Moreover, the therapeutic efficacy of MTX was notably reduced in stressed rats compared to non-stressed, underscoring the detrimental effects of chronic stress on treatment outcomes. Taken together, our results emphasize the importance of considering chronic stress as a critical factor in the management of autoimmune diseases.
Keywords: Autoimmune disease; Chronic stress; Inflammation; Methotrexate; Psoriasis; Rheumatoid arthritis.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflicts of interest: The authors declare no competing interests.
References
-
- Acabchuk RL, Kamath J, Salamone JD, Johnson BT (2017) Stress and chronic illness: the inflammatory pathway. Soc Sci Med 185:166–170. https://doi.org/10.1016/j.socscimed.2017.04.039 - DOI - PubMed - PMC
-
- Adefegha SA, Okeke BM, Oboh G, Ijomone OM, Oyeleye SI (2018) Modulatory effect of eugenol on arginase, nucleotidase, and adenosine deaminase activities of platelets in a carrageenan-induced arthritis rat model: a possible anti-arthritic mechanism of eugenol. Biomed Pharmacother 106:1616–1623. https://doi.org/10.1016/j.biopha.2018.07.143 - DOI - PubMed
-
- Agarwal V, Kaushik AS, Rehman M, Chaudhary R, Jawaid T, Kamal M, Mishra V (2021) Interleukin-6 expression and its modulation by diacerein in a rat model of chronic stress induced cardiac dysfunction. Heliyon 7(12):e08522. https://doi.org/10.1016/j.heliyon.2021.e08522 - DOI - PubMed - PMC
-
- Agarwal V, Kaushik AS, Chaudhary R, Rehman M, Srivastava S, Mishra V (2023) Transcutaneous vagus nerve stimulation ameliorates cardiac abnormalities in chronically stressed rats. Naunyn-Schmiedeberg’s Arch Pharmacol. https://doi.org/10.1007/s00210-023-02611-5 - DOI
-
- Agarwal V, Kaushik AS, Chaudhary R, Rehman M, Srivastava S, Mishra V (2024) Transcutaneous vagus nerve stimulation ameliorates cardiac abnormalities in chronically stressed rats. Naunyn-Schmiedeberg’s Arch Pharmacol 397(1):281–303. https://doi.org/10.1007/s00210-023-02611-5 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
